Sichere Jugendfreizeiten trotz Pandemie

  Taut Science & Service GmbH
Medical Device and Drug Development

Premium Provider for R&D Services in the Life Science Industry

We are a network of highly experienced consultants with complimentary skills and expertise —
in various areas in the development of pharmaceuticals and medical devices.
We support our clients in developing individual solutions that are customized to their projects’ needs.

The new Medical Device Directive (2017) mandates increasing requirements. We are happy to support you.
Both small and big medical device companies appreciate our proven methods to turn an historically grown body of documentation into a future proof information system that supports ever increasing and regionally diverse regulatory requirements.
We support Start-Ups by filling expertise gaps such as regulatory, medical, CMC, documentation. Investors want teams credibly covering all important areas.
Strategies for regulatory approval and market access need to go hand in hand. Only the most relevant health economic data put you on track for a successful launch in a competitive market.
Collaborating with Key Opinion Leaders at eye’s level will enhance your development plan — only diverse discussions will enable the core team to leave the beaten track and strive for true innovation. We are proud of our strong international KOL network which we are happy to share with you.
Prudent pharmacometrics, data mining, and building state-of-the-art statistical models may be one of the most cost efficient exercises in early development. Chances are high the data you need is already available, and we help you find it in commercial or in hospital data bases — evaluations will help to build the right hypothesis for your project. If you need to complement your team for PK/PD modeling of your own data, please contact us.
A sound and concise portfolio of creative enabling studies, pre-clinical as well as experimental early clinical, needs to inform late stage development to increase the chance of success while saving time and resources. All available knowledge needs to be integrated, and statistical models can lead to reliable PK/PD projections.
Patient recruitment in a competitive environment may not always be a function of financal compensation, but very much of personal relation.  Bringing the sponsor team as well as the investigators and site staff behind a shared vision, and regular signs of appreication of everyone’s hard work can make a big difference.
Critical indications require spot-on pharmacological solutions. We are working on platform technologies for inhaled drug administration to circumvent enteral routes that may be unreliable in critically ill patients, and to reduce systemic toxicity.
Underestimating the complexities is an important factor leading to the detrimental track record of critical care studies. This can only be overcome by relentlessly applying existing knowledge and experience, both scientific and operational.
Innovative devices often consist of multiple parts made of special materials. Be it plastics, metals, or others, our material specialists may bring the cutting edge you are looking for
Electronic data capturing has largely eliminated paper documentation. When it comes to patient data, appropriate data protection during storage and transmission is not just a nice-to-have. Our IT partners are specialized in keeping private data private.